Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomi...

Por Swain, S. M., Baselga, J., Miles, D., Im, Y.-H., Quah, C., Lee, L. F., Cortés, J.
Publicado em 2014

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

Por Park, Y H, Jung, H A, Choi, M K, Chang, W, Choi, Y L, Do, I-g, Ahn, J S, Im, Y-H
Publicado em 2014

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first...

Por Lee, S, Park, Y H, Kim, K H, Cho, E Y, Ahn, Y C, Kim, K, Shim, Y-M, Ahn, J S, Park, K, Im, Y-H
Publicado em 2010

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy

Por Yun, J, Kim, K H, Kang, E S, Gwak, G-Y, Choi, M S, Lee, J E, Nam, S J, Yang, J-H, Park, Y H, Ahn, J S, Im, Y-H
Publicado em 2011

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

Por Kim, S T, Kang, W K, Kang, J H, Park, K W, Lee, J, Lee, S-H, Park, J O, Kim, K, Kim, W S, Jung, C W, Park, Y S, Im, Y-H, Park, K
Publicado em 2005

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

Por Kwon, M J, Park, S, Choi, J Y, Oh, E, Kim, Y J, Park, Y-H, Cho, E Y, Kwon, M J, Nam, S J, Im, Y-H, Shin, Y K, Choi, Y-L
Publicado em 2012

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

Por Lee, S-H, Kang, W K, Park, J, Kim, H Y, Kim, J H, Lee, S I, Park, J O, Kim, K, Jung, C W, Park, Y S, Im, Y-H, Lee, M H, Park, K
Publicado em 2004

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

Por Park, Y H, Park, M J, Ji, S H, Yi, S Y, Lim, D H, Nam, D H, Lee, J-I, Park, W, Choi, D H, Huh, S J, Ahn, J S, Kang, W K, Park, K, Im, Y-H
Publicado em 2009